We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Combination Products Require Unique Risk-Benefit Analysis, Says Industry Expert
Combination Products Require Unique Risk-Benefit Analysis, Says Industry Expert
Companies manufacturing drug-device combination products must determine whether the benefits associated with each constituent part and the overall product outweigh the risks, says Susan Neadle, president of Combination Products Consulting Services.